Prime Medicine Inc.

NASDAQ: PRME · Real-Time Price · USD
3.56
-0.08 (-2.20%)
At close: Aug 15, 2025, 3:59 PM
3.65
2.38%
After-hours: Aug 15, 2025, 06:20 PM EDT

Prime Medicine Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
1.11M 1.45M 2.18M 209K 37.77M 591K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 9.13M n/a
Cost of Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 4.57M 4.57M
Gross Profit
n/a 1.45M 2.18M 209K 37.77M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 4.57M -4.57M
Operating Income
-53.38M -52.39M -44.22M -54.23M -55.67M -48.34M -68.04M -51.46M -45.26M -40.03M -38.69M -31.66M -26.3M -19.9M -60.08M -10.43M -8.02M -5.96M
Interest Income
743K 1.18M 1.54M 697K 611K n/a n/a n/a 635K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-52.59M -51.89M -42.28M -52.52M -55.46M -45.63M -65.64M -50.82M -42.35M -39.6M -39.47M -29.14M -29.79M -24.37M -61.53M -18.78M 1.73M -87.28M
Net Income
-52.59M -51.89M -42.28M -52.52M -55.33M -45.76M -65.64M -50.71M -42.38M -39.4M -39.28M -35.71M -35.64M -30.06M -61.44M -22.77M 616K -86.66M
Selling & General & Admin
13.12M 13.28M 12.3M 14.1M 12.6M 11.16M 13.08M 10.49M 10.66M 9.15M 9.63M 6.61M 7.37M 6.22M 7.19M 3.03M 2.32M 1.39M
Research & Development
41.38M 40.56M 34.1M 40.34M 43.07M 37.77M 41.46M 40.97M 34.6M 30.88M 29.06M 25.05M 18.94M 13.68M 52.89M 7.4M 5.7M 4.57M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 238K 11K 12K -1K -4.57M -4.57M
Operating Expenses
54.49M 53.85M 46.41M 54.44M 55.67M 48.93M 54.54M 51.46M 45.26M 40.03M 38.69M 31.66M 26.3M 19.9M 60.08M 10.43M 3.45M 1.39M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
n/a 53.85M 46.41M 54.44M 55.67M 48.93M 54.54M 51.46M 45.26M 40.03M 38.69M 31.66M 26.3M 19.9M 60.08M 10.43M 8.02M 5.96M
Income Tax Expense
n/a n/a n/a n/a -134K 134K 558K -108K 31K -202K -186K 212K -442K -532K 1.38M -2.37M 1.12M -615K
Shares Outstanding (Basic)
129.19M 130.88M 118.6M 119.76M 119.19M 104.47M 97.38M 91.85M 90.47M 89.06M 71.79M 94.34M 71.8M 71.8M 71.8M 71.8M 95.73M 83.76M
Shares Outstanding (Diluted)
129.19M 130.88M 118.6M 119.76M 119.19M 104.47M 97.38M 91.85M 90.47M 89.06M 74.19M 94.34M 71.8M 71.8M 71.8M 71.8M 13.04M 7.33M
EPS (Basic)
-0.41 -0.4 -0.35 -0.44 -0.46 -0.44 -0.67 -0.55 -0.47 -0.44 -0.57 -0.38 -0.5 -0.42 -0.96 -0.32 -0.04 -1.03
EPS (Diluted)
-0.41 -0.4 -0.35 -0.44 -0.46 -0.44 -0.67 -0.55 -0.47 -0.44 -0.55 -0.38 -0.5 -0.42 -0.96 -0.32 -0.32 -11.98
EBITDA
-53.38M -50.69M -42.51M -52.67M -54.13M -47.03M -53.3M -50.22M -44.14M -38.98M -37.82M -31.02M -25.88M -19.61M -59.85M -10.26M -7.89M -5.91M
EBIT
n/a -52.39M -44.22M -54.23M -55.67M -48.34M -54.54M -51.46M -45.26M -40.03M -38.69M -31.66M -26.3M -19.9M -60.08M -10.43M -8.02M -5.96M
Depreciation & Amortization
n/a 1.7M 1.72M 1.56M 1.54M 1.31M 1.25M 1.24M 1.12M 1.05M 870K 631K 430K 293K 229K 167K 122K 50K